Displaying 3781 - 3800 of 4247
| Contract Number | Brand Code | Brand Name | Active Ingredient | Trade Name | Package Size | Formulary Category | Pkg Price | Unit Price | Unit Description | Max. Reimbursable Quantity / Month | Package Description | Manufacturer Code | Manufacturer Name | Agent Code | Agent Name | Benefit | Therapeutic Code | Therapeutic Desc | Drug Contract Start Date | Drug Contract End Date | Status Description | Default Route | Max Repeats | Therapeutic Head | Amend Date | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40 | A6812 | COMBIVIR 150MG | 300MG TAB (GSK/COL) LAMIVUDINE | ZIDOVUDINE | LAMIVUDINE|ZIDOVUDINE | COMBIVIR | 60'S | BL | 135.02 | 2.25 | TABLET | 0 | TAB | GSK | GLAXOSMITHKLINE | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2022-05-31 | Delete from contract | Oral | 0 | ANTI-INFECTIVE AGENTS | 2022-04-19 | |||
| 41 | A6812 | COMBIVIR 150MG|300MG TAB (GSK) LAMIVUDINE|ZIDOVUDINE (BL) | LAMIVUDINE|ZIDOVUDINE | COMBIVIR | 60'S | BL | 149.83 | 2.4972 | TAB | 60 | BOX | GSK | GLAXOSMITHKLINE | COL | COLLINS LTD | 08180820 | NRTI | 2024-04-01 | 2026-03-31 | ORAL | 6 | NRTI | |||||
| 40 | A681AM | EFAVIRENZ | EMTRICITABINE | TENOFOVIR 600MG | 200MG | 300MG TAB (MAT/AHI) | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | 30'S | BL | 27.59 | 0.92 | TABLET | 0 | TAB | MAT | MYLAN LABORATORIES | AHI | ARMSTRONG HEALTHCARE INC | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681AM | EFAVIRENZ|EMTRICITABINE|TENOFOVIR 600MG|200MG|300MG TAB (MAT (BL) | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | 30'S | BL | 30.17 | 1.0058 | TAB | 60 | BOX | MAT | MYLAN LABORATORIES | AHI | ARMSTRONG HEALTHCARE INC | 081892 | ANTIVIRALS, MISCELLANEOUS | 2024-04-01 | 2026-03-31 | ORAL | 6 | ANTIVIRALS, MISCELLANEOUS | |||||
| 40 | A681BN | KIVEXA 600MG | 300MG TAB (GSK/COL) ABACAVIR | LAMIVUDINE | ABACAVIR|LAMIVUDINE | KIVEXA | 30'S | BL | 162.04 | 5.40 | TABLET | 0 | TAB | GSK | GLAXOSMITHKLINE | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 40 | A681EY | VONAVIR 600MG | 200MG | 300MG TAB (EMC/COL) EFAVIRENZ | EMTRICITABINE | TENOFOVI More ... | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | VONAVIR | 30'S | BL | 81.55 | 2.72 | TABLET | 0 | TAB | EMC | EMCURE PHARMACEUTICALS LTD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681EY | VONAVIR 600MG|200MG|300MG TAB (EMC) EFAVIRENZ|EMTRICITABINE| (BL) | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | VONAVIR | 30'S | BL | 86.99 | 2.8995 | TAB | 60 | BOX | EMC | EMCURE PHARMACEUTICALS LTD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2024-04-01 | 2026-03-31 | ORAL | 6 | ANTIRETROVIRALS MISCELLANEOUS | |||||
| 40 | A681FC | KIVALA 600MG | 300MG TAB (REM/SBI) ABACAVIR | LAMIVUDINE | ABACAVIR|LAMIVUDINE | KIVALA | 30'S | BL | 82.72 | 2.76 | TABLET | 0 | TAB | REM | REMEDICA LTD | SBI | MASSY DISTRIBUTION (BDOS) LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681FS | EXATRON 200MG|245MG TAB (REM) EMTRICITAB (BL) | EMTRICITABINE|TENOFOVIR | EXATRON | 30'S | BL | 76.11 | 2.5371 | TAB | 0 | BOTT | REM | REMEDICA LTD | SBI | MASSY DISTRIBUTION (BDOS) LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2024-04-01 | 2026-03-31 | ORAL | 0 | ANTIRETROVIRALS MISCELLANEOUS | |||||
| 40 | A681FT | TAVIN-EM 200MG | 300MG TAB (EMC/COL) EMTRICITABINE | TENOFOVIR | EMTRICITABINE|TENOFOVIR | TAVIN-EM | 30'S | BL | 21.20 | 0.71 | TABLET | 0 | TAB | EMC | EMCURE PHARMACEUTICALS LTD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681FT | TAVIN-EM 200MG|300MG TAB (EMC) EMTRICITABINE|TENOFOVIR (BL) | EMTRICITABINE|TENOFOVIR | TAVIN-EM | 30'S | BL | 28.13 | 0.9378 | TAB | 60 | BOX | EMC | EMCURE PHARMACEUTICALS LTD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2024-04-01 | 2026-03-31 | ORAL | 6 | ANTIRETROVIRALS MISCELLANEOUS | |||||
| 40 | A681GL | TRUVADA 200MG | 300MG TAB (GIL/COL) EMTRICITABINE | TENOFOVIR | EMTRICITABINE|TENOFOVIR | TRUVADA | 30'S | BL | 129.53 | 4.32 | TABLET | 0 | TAB | GIL | GILEAD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681GL | TRUVADA 200MG|300MG TAB (GIL) EMTRICITABINE|TENOFOVIR (BL) | EMTRICITABINE|TENOFOVIR | TRUVADA | 30'S | BL | 129.53 | 4.3176 | TAB | 60 | BOX | GIL | GILEAD | COL | COLLINS LTD | 081892 | ANTIVIRALS, MISCELLANEOUS | 2024-04-01 | 2026-03-31 | ORAL | 6 | ANTIVIRALS, MISCELLANEOUS | |||||
| 40 | A681GP | ATAZOR-R 300MG | 100MG TAB (EMC/COL) ATAZANAVIR | RITONAVIR | ATAZANAVIR|RITONAVIR | ATAZOR-R | 30'S | BL | 75.03 | 2.50 | TABLET | 0 | TAB | EMC | EMCURE PHARMACEUTICALS LTD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681GP | ATAZOR-R 300MG|100MG TAB (EMC) ATAZANAVIR|RITONAVIR (BL) | ATAZANAVIR|RITONAVIR | ATAZOR-R | 30'S | BL | 67.96 | 2.2653 | TAB | 60 | BOX | EMC | EMCURE PHARMACEUTICALS LTD | COL | COLLINS LTD | 081892 | ANTIVIRALS, MISCELLANEOUS | 2024-04-01 | 2026-03-31 | ORAL | 6 | ANTIVIRALS, MISCELLANEOUS | |||||
| 40 | A681GW | BIKTARVY 50MG | 200MG | 25MG TAB (GIL/COL) BICTEGRAVIR | EMTRICITABINE | TENOFOV More ... | BICTEGRAVIR|EMTRICITABINE|TENOFOVIR | BIKTARVY | 30'S | BL | 321.99 | 10.73 | TABLET | 0 | TAB | GIL | GILEAD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681GW | BIKTARVY 50MG|200MG|25MG TAB (GIL) BICTEGRAVIR|EMTRICITABINE (BL) | BICTEGRAVIR|EMTRICITABINE|TENOFOVIR | BIKTARVY | 30'S | BL | 290.83 | 9.6944 | TAB | 60 | BOX | GIL | GILEAD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2024-04-01 | 2026-03-31 | ORAL | 6 | ANTIRETROVIRALS MISCELLANEOUS | |||||
| 40 | A681GX | GENVOYA 150MG | 150MG | 200MG | 10MG TAB (GIL/COL) COBICSTAT | ELVITEGRAVIR | EM More ... | COBICSTAT|ELVITEGRAVIR|EMTRICITABINE|TENOFOVIR | GENVOYA | 30'S | BL | 321.99 | 10.73 | TABLET | 0 | TAB | GIL | GILEAD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681GX | GENVOYA 150MG|150MG|200MG|10MG TAB (GIL) COBICSTAT|ELVITEGRA (BL) | COBICSTAT|ELVITEGRAVIR|EMTRICITABINE|TENOFOVIR | GENVOYA | 30'S | BL | 321.99 | 10.7329 | TAB | 60 | BOX | GIL | GILEAD | COL | COLLINS LTD | 08180812 | INTEGRASE INHIBITORS | 2024-04-01 | 2026-03-31 | ORAL | 6 | INTEGRASE INHIBITORS | |||||
| 40 | A681HB | ZOVILAM 150MG | 300MG TAB (MAT/AHI) LAMIVUDINE | ZIDOVUDINE | LAMIVUDINE|ZIDOVUDINE | ZOVILAM | 60'S | BL | 21.20 | 0.35 | TABLET | 0 | TAB | MAT | MYLAN LABORATORIES | AHI | ARMSTRONG HEALTHCARE INC | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||